West Nile Virus Market Size and Trends

The West Nile virus market size is expected to reach US$ 1,097.8 Mn by 2030, from US$ 634.8 million in 2023, at a CAGR of 8.1% during the forecast period. West Nile virus is a mosquito-borne disease that can cause neurological disorders and death in humans. The infection is mostly asymptomatic but can lead to West Nile fever or severe West Nile disease in some cases. Vaccines and therapeutics are available for treatment. The rising prevalence of the West Nile virus and increasing Research & Development investments are key drivers of the market.

Figure 1. Global West Nile Virus Market Share (%), by Region, 2023

West Nile Virus Market Drivers

Increasing Incidence of West Nile Virus Infection: The rising incidence of West Nile virus infection globally is a major factor driving the West Nile virus market’s growth. According to the World Health Organization (WHO), the number of West Nile fever cases reported in 2020 increased substantially as compared to previous years. For instance, in Europe, 955 confirmed cases were reported in 2020, compared to 223 cases in 2019. The increasing disease burden is creating significant demand for effective diagnostics, vaccines, and therapies. Public health agencies are also taking initiatives to increase awareness and curb infection rates. These factors will continue to drive market growth during the forecast period.
Investments in R&D for Novel Therapies: Significant investments are being made by biopharmaceutical companies to develop innovative therapies and vaccines for the West Nile virus. Several drug candidates are in the pipeline, including WNV-VLP vaccine by GeoVax Labs, mRNA vaccines by Moderna, and antibody therapies by Vigil Neuroscience. Moreover, research is underway to find novel drug targets and action mechanisms for treatment. The R&D initiatives are aided by government funding support. The introduction of effective pipeline therapies upon approval will boost the West Nile virus market.
Advancements in Diagnostic Technologies: The incorporation of molecular and immunodiagnostic techniques for detecting West Nile virus is favoring market growth. Advancements such as RT-PCR assays allow quick and accurate diagnosis in the early stages of infection. Point-of-care immunodiagnostic tests are facilitating testing in small clinics and hospital settings. Market players are increasingly investing in R&D for diagnostic biomarkers and assays. The launch of highly sensitive and specific diagnostics is contributing positively to the overall market outlook.
Favorable Government Policies and Initiatives: The implementation of awareness campaigns regarding preventive measures for West Nile disease is contributing to the growth of vaccines and diagnostics. Government bodies such as the US CDC actively provide people with information on avoiding mosquito bites and checking vector populations. The WHO and regional healthcare agencies are undertaking initiatives for the early detection and control of outbreaks. Additionally, funding and investments for healthcare infrastructure development will favor market progress.

West Nile Virus Market Trends

Strategic Partnerships and Collaborations: Strategic partnerships and collaborative efforts have become increasingly important in recent years for organizations operating in the West Nile virus market...
Research and Development: Research and development in the area of West Nile virus diagnosis and treatment has seen significant advances in recent years...